Stelexis BioSciences, Inc. Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Stelexis Therapeutics is a New York, New York–based biotechnology research company focused on cancer therapeutics. It was founded by Deerfield, with headquarters at 780 3rd Avenue in New York. The firm aims to transform how cancer is treated and how patient care is managed through the discovery and development of novel drugs. In 2026, Stelexis participated in ASCO 2026, presenting positive Phase 1 data for eganelisib in relapsed or refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes. The presentation signals ongoing clinical activity in its cancer therapeutics program.